JP2003506403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003506403A5 JP2003506403A5 JP2001514945A JP2001514945A JP2003506403A5 JP 2003506403 A5 JP2003506403 A5 JP 2003506403A5 JP 2001514945 A JP2001514945 A JP 2001514945A JP 2001514945 A JP2001514945 A JP 2001514945A JP 2003506403 A5 JP2003506403 A5 JP 2003506403A5
- Authority
- JP
- Japan
- Prior art keywords
- piperidinyl
- carbonyl
- dihydro
- dibromo
- phenylalanyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19937304A DE19937304C2 (de) | 1999-08-10 | 1999-08-10 | Verwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen |
| DE19937304.3 | 1999-08-10 | ||
| PCT/EP2000/007613 WO2001010425A2 (de) | 1999-08-10 | 2000-08-05 | Verwendung von cgrp-antagonisten und cgrp-release-hemmern zur bekämpfung menopausaler hitzewallungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003506403A JP2003506403A (ja) | 2003-02-18 |
| JP2003506403A5 true JP2003506403A5 (https=) | 2007-09-27 |
Family
ID=7917551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001514945A Pending JP2003506403A (ja) | 1999-08-10 | 2000-08-05 | 閉経期の顔面潮紅を治療するためのｃｇｒｐアンタゴニスト及びｃｇｒｐ放出インヒビターの使用 |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP1207884B1 (https=) |
| JP (1) | JP2003506403A (https=) |
| KR (1) | KR100713573B1 (https=) |
| CN (1) | CN1166361C (https=) |
| AR (1) | AR025078A1 (https=) |
| AT (1) | ATE281168T1 (https=) |
| AU (1) | AU777709B2 (https=) |
| BG (1) | BG65366B1 (https=) |
| BR (1) | BR0013009A (https=) |
| CA (1) | CA2378428C (https=) |
| CZ (1) | CZ300513B6 (https=) |
| DE (2) | DE19937304C2 (https=) |
| EA (1) | EA007531B1 (https=) |
| EE (1) | EE04928B1 (https=) |
| ES (1) | ES2231243T3 (https=) |
| HK (1) | HK1046854B (https=) |
| HR (1) | HRP20020117A2 (https=) |
| HU (1) | HUP0202397A3 (https=) |
| IL (1) | IL148057A (https=) |
| MX (1) | MXPA02001373A (https=) |
| MY (1) | MY129668A (https=) |
| NO (1) | NO20020605D0 (https=) |
| NZ (1) | NZ517367A (https=) |
| PL (1) | PL198483B1 (https=) |
| PT (1) | PT1207884E (https=) |
| SK (1) | SK285587B6 (https=) |
| TR (1) | TR200200359T2 (https=) |
| TW (1) | TWI285550B (https=) |
| UA (1) | UA73137C2 (https=) |
| WO (1) | WO2001010425A2 (https=) |
| YU (1) | YU8302A (https=) |
| ZA (1) | ZA200200997B (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19952147A1 (de) | 1999-10-29 | 2001-05-03 | Boehringer Ingelheim Pharma | Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE10139410A1 (de) * | 2001-08-17 | 2003-02-27 | Boehringer Ingelheim Pharma | Verwendung von BIBN4096 in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne |
| WO2003050109A1 (en) * | 2001-12-12 | 2003-06-19 | Eli Lilly And Company | Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases |
| DE10206770A1 (de) * | 2002-02-19 | 2003-08-28 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Pulverinhalativums enthaltend ein Salz des CGRP-Antagonisten BIBN4096 |
| US6900317B2 (en) | 2002-02-19 | 2005-05-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them |
| DE10207026A1 (de) * | 2002-02-20 | 2003-08-28 | Boehringer Ingelheim Kg | Pulverinhalativum, enthaltend den CGRP-Antagonisten BIBN4096 und Verfahren zu dessen Herstellung |
| DE10227294A1 (de) * | 2002-06-19 | 2004-01-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Zubereitungen zur intranasalen Applikation ausgewählter, von Aminosäuren abgeleiteter CGRP-Antagonisten sowie Verfahren zu deren Herstellung |
| DE10250080A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| US7595312B2 (en) | 2002-10-25 | 2009-09-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
| DE10300973A1 (de) * | 2003-01-14 | 2004-07-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Carbonsäuren und deren Ester, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| WO2005004869A1 (en) * | 2003-07-07 | 2005-01-20 | Boehringer Ingelheim International Gmbh | Use of cgrp antagonists in treatment and prevention of hot flushes in prostate cancer patients |
| CN100418948C (zh) * | 2003-07-15 | 2008-09-17 | 麦克公司 | 羟基吡啶cgrp受体抗拮抗剂 |
| DE10338399A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Mikropartikel, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-Iysyl]-4-(4-pyridinyl)-piperazin, Verfahren zu deren Herstellung sowie deren Verwendung als Inhalaltionspulver |
| DE102004015723A1 (de) | 2004-03-29 | 2005-10-20 | Boehringer Ingelheim Pharma | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| US7696195B2 (en) | 2004-04-22 | 2010-04-13 | Boehringer Ingelheim International Gmbh | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| DE102004019492A1 (de) * | 2004-04-22 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE102004063755A1 (de) * | 2004-12-29 | 2006-07-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von CGRP-Antagonisten zur Behandlung und Vorbeugung von Hitzewallungen bei Patienten mit Prostatakrebs |
| DE102004063752A1 (de) * | 2004-12-29 | 2006-07-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung ausgewählter CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen |
| EP1770091A1 (de) | 2005-09-29 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| US7491717B2 (en) | 2005-03-23 | 2009-02-17 | Boehringer Ingelheim International Gmbh | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| US7439237B2 (en) | 2005-04-15 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2132855T3 (es) * | 1995-09-07 | 1999-08-16 | Oreal | Extracto de iridaceas y composiciones que lo contienen. |
| US5910482A (en) * | 1996-03-19 | 1999-06-08 | Board Of Regents, The University Of Texas System | Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor |
| US5710024A (en) * | 1996-07-23 | 1998-01-20 | Smithkline Beecham Corporation | Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44) |
| DE59711622D1 (de) * | 1996-09-10 | 2004-06-17 | Boehringer Ingelheim Pharma | Abgewandelte aminosäuren, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE19911039A1 (de) * | 1999-03-12 | 2000-09-14 | Boehringer Ingelheim Pharma | Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
-
1999
- 1999-08-10 DE DE19937304A patent/DE19937304C2/de not_active Expired - Fee Related
-
2000
- 2000-05-08 UA UA2002031932A patent/UA73137C2/uk unknown
- 2000-08-05 EE EEP200200061A patent/EE04928B1/xx not_active IP Right Cessation
- 2000-08-05 HK HK02108347.1A patent/HK1046854B/zh not_active IP Right Cessation
- 2000-08-05 HU HU0202397A patent/HUP0202397A3/hu unknown
- 2000-08-05 WO PCT/EP2000/007613 patent/WO2001010425A2/de not_active Ceased
- 2000-08-05 DE DE50008527T patent/DE50008527D1/de not_active Expired - Lifetime
- 2000-08-05 EA EA200200207A patent/EA007531B1/ru not_active IP Right Cessation
- 2000-08-05 BR BR0013009-5A patent/BR0013009A/pt not_active Application Discontinuation
- 2000-08-05 TR TR2002/00359T patent/TR200200359T2/xx unknown
- 2000-08-05 CA CA002378428A patent/CA2378428C/en not_active Expired - Fee Related
- 2000-08-05 NZ NZ517367A patent/NZ517367A/en unknown
- 2000-08-05 HR HR20020117A patent/HRP20020117A2/hr not_active Application Discontinuation
- 2000-08-05 KR KR1020027001796A patent/KR100713573B1/ko not_active Expired - Fee Related
- 2000-08-05 EP EP00958385A patent/EP1207884B1/de not_active Expired - Lifetime
- 2000-08-05 JP JP2001514945A patent/JP2003506403A/ja active Pending
- 2000-08-05 IL IL148057A patent/IL148057A/en not_active IP Right Cessation
- 2000-08-05 CZ CZ20020497A patent/CZ300513B6/cs not_active IP Right Cessation
- 2000-08-05 AT AT00958385T patent/ATE281168T1/de not_active IP Right Cessation
- 2000-08-05 CN CNB008116156A patent/CN1166361C/zh not_active Expired - Fee Related
- 2000-08-05 ZA ZA200200997A patent/ZA200200997B/en unknown
- 2000-08-05 SK SK197-2002A patent/SK285587B6/sk unknown
- 2000-08-05 AU AU69928/00A patent/AU777709B2/en not_active Ceased
- 2000-08-05 MX MXPA02001373A patent/MXPA02001373A/es active IP Right Grant
- 2000-08-05 PT PT00958385T patent/PT1207884E/pt unknown
- 2000-08-05 PL PL364049A patent/PL198483B1/pl not_active IP Right Cessation
- 2000-08-05 YU YU8302A patent/YU8302A/sh unknown
- 2000-08-05 ES ES00958385T patent/ES2231243T3/es not_active Expired - Lifetime
- 2000-08-08 MY MYPI20003601A patent/MY129668A/en unknown
- 2000-08-08 TW TW089115923A patent/TWI285550B/zh not_active IP Right Cessation
- 2000-08-09 AR ARP000104098A patent/AR025078A1/es unknown
-
2002
- 2002-02-06 BG BG106391A patent/BG65366B1/bg unknown
- 2002-02-07 NO NO20020605A patent/NO20020605D0/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003506403A5 (https=) | ||
| ZA200200997B (en) | Use of CGRP antagonists and CGRP release inhibitors for controlling menopausal hot flushes. | |
| US6521609B1 (en) | Use of CGRP antagonists and CGRP release inhibitors for combating menopausal hot flushes | |
| RU2008141374A (ru) | Фармацевтическая композиция, содержащая по крайнер мере один ингибитор ркс и по крайней мере один ингибитор киназы jak3, предназначенная для лечения аутоиммунных нарушений | |
| JP2007513957A5 (https=) | ||
| US20120214819A1 (en) | Use of N--4-(3-pyridyl)-2-pyridine-amine for the Treatment of Pulmonary Hypertension | |
| HUP0400349A2 (hu) | AIDS kezelésére alkalmazható CCR5 antagonisták és ezeket tartalmazó gyógyszerkészítmények | |
| JP2009532438A5 (https=) | ||
| PT1487424E (pt) | 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-il-amino)fenil]-benzamida para o tratamento doenças mediadas por ang ii | |
| KR20110051194A (ko) | 섬유증의 치료를 위한 피리미딜아미노벤즈아미드 유도체의 용도 | |
| CA2563687A1 (en) | Use of a cgrp-antagonist combined with a serotonin-reuptake inhibitor in order to treat migraines | |
| MXPA05009290A (es) | Derivados heterociclicos que contienen nitrogeno que tienen estirilo 2,6-disustituido. | |
| US20050233980A1 (en) | CGRP-antagonist in combination with a serotonin-reuptake inhibitor for the treatment of migraine | |
| JP2020510071A (ja) | 特発性肺線維症の治療 | |
| TW202140015A (zh) | 用於治療癌症之表皮生長因子受體酪胺酸激酶抑制劑 | |
| US20050032783A1 (en) | Use of CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients | |
| US20190175551A1 (en) | Medicine for treating renal disease | |
| WO1998057643A1 (en) | Use of draflazine-analogues for treating pain | |
| AU2005205914A1 (en) | Combination of organic compounds | |
| CA2531407A1 (en) | Use of cgrp antagonists in treatment and prevention of hot flushes in prostate cancer patients | |
| TH75066A (th) | เพพไทด์ รีเซพเตอร์ แอนทาโกนิสท์ที่สัมพันธ์กับคัลซิโทนิน ยีน |